<DOC>
	<DOCNO>NCT02159742</DOCNO>
	<brief_summary>From 1996-present , used photodynamic therapy ( PDT ) treat number neoplastic disease prospective research protocol ( head neck cancer , pleural malignancy , peritoneal carcinomatosis sarcomatosis prostate cancer ) well FDA approve label compassionate exemption indication ( neoplasms skin , bronchus , esophagus , head neck pleura ) . The goal treatment maximize quality life organ function minimize chance tumor recurrence . As , would like retrospectively review treatment parameter patient undergo/underwent PDT ( include operative note photodynamic therapy record ) treatment outcome ( include organ function , performance status , tumor recurrence , laboratory value data present routinely document follow visit ) . For patient die lose follow-up prior initiation study , retrospective review available data perform . For patient still actively follow PDT receive PDT initiation study , inform consent obtain obtain continued follow-up data prospectively previous data collect retrospectively.. These subject continue receive care current physician accord standard medical practice attempt make alter type follow-up , radiologic diagnostic study medical treatment result enrollment study . All data de-identified add already exist PDT treatment outcome databases outcomes analysis , quality improvement reporting result abstract manuscript form .</brief_summary>
	<brief_title>Prospective Follow-up Outcomes Patients Receiving Photodynamic Therapy Neoplastic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Subjects age 18 great Subjects undergone PDT diagnosis neoplastic disease direction Penn physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Adult subject</keyword>
	<keyword>history</keyword>
	<keyword>treatment</keyword>
	<keyword>photodynamic therapy</keyword>
</DOC>